Aldeyra Therapeutics, Inc. ALDX
Set alert
0.58 USD +0.02 +4.09%
At close · Nov 2
0.57 -0.01 -1.99%
After hours · Nov 2, 4:00 PM ET
0.5271 Day range 0.5994
0.5271 52-week range 5.93
- YTD
- -88.74%
- 1 year
- -88.50%
- Open
- 0.5601
- Prev close
- 0.5603
- Mkt cap
- 35.18M
- Vol
- 906.10K
- Avg vol
- 1.16M
- EPS
- -0.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5271
- High
- 0.5994
- Forward P/E
- -7.80
- Beta
- 1.43
- Short ratio
- 6.19
- Inst. own
- 62.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 3, 2024
- 50-d avg
- 5.12
- 200-d avg
- 4.48
- 1y target
- 10.00
MAX chart
Events in this range
- Aug 3, 2023Earnings: -0.15; estimate -0.31; surprise 51.61%
- Nov 3, 2023Earnings: -0.14; estimate 0; surprise —%
- Mar 7, 2024Earnings: -0.08; estimate -0.21; surprise 61.9%
- Apr 3, 2024Rating: Oppenheimer · Perform → Outperform
- May 2, 2024Earnings: -0.14; estimate -0.08; surprise -75%
- May 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 6, 2024Rating: Oppenheimer · Outperform → Outperform
- Aug 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 3, 2024Earnings: —; estimate -0.21; surprise —%
- Nov 7, 2024Earnings: -0.25; estimate -0.25; surprise 0%
Signals (55)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| MACD: Sell Signal | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| SMA: Bullish | Mar 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Oct 1, 2021 | 5 years ago |
| SMA: Bearish | Jul 1, 2021 | 5 years ago |
| SMA: Bullish | Nov 1, 2020 | 6 years ago |
| SMA: Bearish | Oct 1, 2020 | 6 years ago |
| SMA: Bullish | Sep 1, 2020 | 6 years ago |
| MACD: Buy Signal | Aug 1, 2020 | 6 years ago |
| SMA: Bullish | Jul 1, 2020 | 6 years ago |
| SMA: Bearish | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | May 1, 2020 | 6 years ago |
| SMA: Bearish | Dec 1, 2019 | 6 years ago |
| SMA: Bearish | Dec 1, 2019 | 6 years ago |
| SMA: Bullish | Nov 1, 2019 | 7 years ago |
| SMA: Bullish | Nov 1, 2019 | 7 years ago |
| SMA: Bearish | May 1, 2019 | 7 years ago |
| MACD: Sell Signal | Mar 1, 2019 | 7 years ago |
| SMA: Bearish | Dec 1, 2018 | 7 years ago |
| RSI: Overbought | Sep 1, 2018 | 8 years ago |
| SMA: Bullish | Aug 1, 2018 | 8 years ago |
| SMA: Bearish | Jul 1, 2018 | 8 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| MACD: Buy Signal | Sep 1, 2017 | 9 years ago |
| MACD: Sell Signal | Aug 1, 2017 | 9 years ago |
| MACD: Buy Signal | May 1, 2017 | 9 years ago |
| MACD: Sell Signal | Apr 1, 2017 | 9 years ago |
| SMA: Bearish | Oct 1, 2016 | 10 years ago |
| SMA: Bullish | Sep 1, 2016 | 10 years ago |
| SMA: Bearish | Aug 1, 2016 | 10 years ago |
| SMA: Bullish | Jul 1, 2016 | 10 years ago |
| SMA: Bearish | Aug 1, 2015 | 11 years ago |
| SMA: Bullish | Jul 1, 2015 | 11 years ago |
| SMA: Bearish | May 1, 2015 | 11 years ago |
Financial health
Altman Z-Score
-13.06 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -9.2×
FY 2016 5y median -5.5× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 7.0×
FY 2016 5y median 2.7× FY 2025
P/FCF -9.3×
FY 2016 5y median -6.9× FY 2025
EV/EBITDA -8.1×
FY 2016 5y median -4.6× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -10.7%
FY 2016 5y median -14.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -76.5%
FY 2016 5y median -41.1% FY 2025
ROIC -59.0%
FY 2016 5y median -37.5% FY 2025
ROA -47.0%
FY 2016 5y median -34.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 41.3%
FY 2016 FY 2025
EPS (diluted) 40.4%
FY 2016 FY 2025
Free Cash Flow 22.8%
FY 2016 FY 2025
Financial Health
Current Ratio 2.6×
FY 2016 5y median 6.6× FY 2025
Quick Ratio 2.6×
FY 2016 5y median 6.6× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.7×
FY 2016 5y median 2.1× FY 2025
Interest Coverage -18.5×
FY 2016 5y median -31.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31